AI assistant
Sending…
AVADEL PHARMACEUTICALS PLC — Director's Dealing 2019
Jan 18, 2019
31920_dirs_2019-01-18_0abff0e3-8983-4c42-a3bc-257ff595a1b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2018-12-28
Reporting Person: ANDERSON MICHAEL S (Director, See Remarks)
More from AVADEL PHARMACEUTICALS PLC
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Delisting Announcement
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12